Cargando…

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer

Detalles Bibliográficos
Autores principales: Zhang, Mengjun, Liu, Yunduo, Liu, Yuan, Hou, Siyu, Li, Hao, Ma, Ying, Wang, Can, Chen, Xiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449800/
https://www.ncbi.nlm.nih.gov/pubmed/36092866
http://dx.doi.org/10.3389/fgene.2022.978493
_version_ 1784784379128578048
author Zhang, Mengjun
Liu, Yunduo
Liu, Yuan
Hou, Siyu
Li, Hao
Ma, Ying
Wang, Can
Chen, Xiuwei
author_facet Zhang, Mengjun
Liu, Yunduo
Liu, Yuan
Hou, Siyu
Li, Hao
Ma, Ying
Wang, Can
Chen, Xiuwei
author_sort Zhang, Mengjun
collection PubMed
description
format Online
Article
Text
id pubmed-9449800
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94498002022-09-08 Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer Zhang, Mengjun Liu, Yunduo Liu, Yuan Hou, Siyu Li, Hao Ma, Ying Wang, Can Chen, Xiuwei Front Genet Genetics Frontiers Media S.A. 2022-08-24 /pmc/articles/PMC9449800/ /pubmed/36092866 http://dx.doi.org/10.3389/fgene.2022.978493 Text en Copyright © 2022 Zhang, Liu, Liu, Hou, Li, Ma, Wang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zhang, Mengjun
Liu, Yunduo
Liu, Yuan
Hou, Siyu
Li, Hao
Ma, Ying
Wang, Can
Chen, Xiuwei
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_full Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_fullStr Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_full_unstemmed Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_short Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_sort corrigendum: a potential indicator arrdc2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449800/
https://www.ncbi.nlm.nih.gov/pubmed/36092866
http://dx.doi.org/10.3389/fgene.2022.978493
work_keys_str_mv AT zhangmengjun corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT liuyunduo corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT liuyuan corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT housiyu corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT lihao corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT maying corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT wangcan corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT chenxiuwei corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer